Lectin-Based Method for Evaluation of Neuraminidase Activity and Its Inhibitors
Zuzana
Hľasová
1
Stanislav
Miertuš
1,2
Miroslav
Ondrejovič
1
Jaroslav
Katrlík
3
1University of Ss. Cyril and Methodius in Trnava, Faculty of Natural Sciences, Department of Biotechnology, Nám. J. Herdu 2, 917 01 Trnava, Slovak Republic
2International Centre for Applied Research and Sustainable Technology, Jamnického 19, 841 04 Bratislava, Slovak Republic
3Slovak Academy of Sciences, Institute of Chemistry, Department of Glycobiotechnology, Dúbravská cesta 9, 845 38, Bratislava, Slovak Republic
tucekova.zuzana@gmail.com
Neuraminidases are hydrolytic enzymes acting on glycosidic linkage of terminal sialic acids in glycoproteins, glycolipids, oligosaccharides, colominic acids and synthetic substrates [1]. Function of these enzymes is essential in pathogenesis of many viral and bacterial infections [2]. Discovery of potent neuraminidase inhibitors, as well as development of high-throughput methods for their activity evaluation is therefore desirable in treatment and prophylaxis of these diseases [3 - 4]. In our work, we have developed a method for evaluation of neuraminidase activity and its inhibitors. In the developed lectin-based method, the lectin Peanut agglutinin (PNA) was used for the determination of galactose moiety exposed after cleavage of sialic acid from immobilized fetuin by neuraminidase from Clostridium perfringens. Described method was performed in microtiter-plates with quantification of desialylation by fluorescent dye. Our next aim is miniaturization of this method to microarray format.
This work was supported by the SRDA grants APVV-14-0294, APVV-15-0111, APVV-16-0088 and VEGA 2/0137/18.
[1] KANEHISA, M. et al. KEGG: New perspectives on genomes, pathways, diseases and drugs. In Nucleic Acids Research. 2017. Vol. 45, no. D1, s. D353–D361.
[2] CORFIELD, T. Bacterial sialidases - roles in pathogenicity and nutrition. In Glycobiology. 1992. Vol. 2, no. 6, s. 509–521.
[3] KASHIF, M. et al. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi. In Journal of Drug Targeting. 2017. Vol. 25, no. 6, s. 485–498.
[4] SCHWERDTFEGER, S.M. et al. Sialidases in biological systems. In Pharmazie. 2010. Vol. 65, no. 8, s. 551–561.
Administrátor
Dakujem, s pozdravom, P. Farkas
Pasívny
Moderátor
Pasívny
Pasívny
V grafe 1C je zobrazený vplyv nedostatočného vymytia reakčných roztokov na priebeh nasledujúcej reakcie/reakcií. V prípade BSA nedochádza k zásadnej z...Zobraziť celý komentár